JANTOVEN

Serial Number 76465738
Registration 2858599
800

Registration Progress

Application Filed
Nov 12, 2002
Under Examination
Jul 22, 2003
Approved for Publication
Apr 9, 2003
Published for Opposition
Apr 29, 2003
Registered
Jun 29, 2004

Trademark Image

JANTOVEN

Basic Information

Serial Number
76465738
Registration Number
2858599
Filing Date
November 12, 2002
Registration Date
June 29, 2004
Published for Opposition
April 29, 2003
Renewal Date
June 29, 2024
Drawing Code
1

Status Summary

Current Status
Active
Status Code
800
Status Date
Jul 29, 2024
Registration
Registered
Classes
005

Rights Holder

UPSHER-SMITH LABORATORIES, LLC

16
Address
6701 EVENSTAD DRIVE
MAPLE GROVE, MN 55369

Ownership History

Upsher-Smith Laboratories, Inc.

Original Applicant
03
Maple Grove, MN

Upsher-Smith Laboratories, Inc.

Owner at Publication
03
Maple Grove, MN

Upsher-Smith Laboratories, Inc.

Original Registrant
03
Maple Grove, MN

UPSHER-SMITH LABORATORIES, LLC

New Owner After Registration #1
16
MAPLE GROVE, MN

Legal Representation

Attorney
Makiko Coffland

USPTO Deadlines

Next Deadline
3158 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 2004-06-29)
Due Date
June 29, 2034
Grace Period Ends
December 29, 2034

Application History

38 events
Date Code Type Description Documents
Oct 30, 2024 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Oct 30, 2024 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jul 29, 2024 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Jul 29, 2024 RNL2 Q REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) Loading...
Jul 29, 2024 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Jul 29, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
May 7, 2024 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Jun 29, 2023 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Jun 2, 2020 CORV 1 REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED Loading...
Apr 2, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 2, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 2, 2020 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Apr 2, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 2, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 2, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 23, 2017 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jul 11, 2013 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Jul 11, 2013 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Jul 11, 2013 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Jul 11, 2013 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jul 1, 2013 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Jul 25, 2012 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 2, 2010 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 2, 2010 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 10, 2010 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Jun 22, 2010 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jun 4, 2010 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jun 29, 2004 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 31, 2004 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Feb 18, 2004 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jan 15, 2004 IUAF S USE AMENDMENT FILED Loading...
Jan 15, 2004 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Nov 3, 2003 MAIL I PAPER RECEIVED Loading...
Jul 22, 2003 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 29, 2003 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 9, 2003 NPUB O NOTICE OF PUBLICATION Loading...
Mar 9, 2003 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 26, 2003 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely anticoagulants; pharmaceutical preparations for the treatment of heart conditions and coronary artery disease
First Use Anywhere: Oct 14, 2003
First Use in Commerce: Oct 14, 2003

Classification

International Classes
005